Medtronic CEO pushes back on criticisms it has a ‘spotty record’

Medtronic CEO Omar Ishrak pushed back Tuesday on a Barclays research note that said the U.S. medical device maker took a “step back” following disappointing comments on the company’s outlook from Ishrak at the 2019 J.P. Morgan Healthcare Conference.

Source link

Leave a Comment

New California governor tackles drug prices in first actWoman given erectile dysfunction cream for dry eye